Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis
Top Cited Papers
- 1 December 2005
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 366 (9502), 2026-2033
- https://doi.org/10.1016/s0140-6736(05)67814-2
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic reviewBMJ, 2004
- Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IVJournal of Human Hypertension, 2004
- Blood Pressure Predicts Risk of Developing End-Stage Renal Disease in Men and WomenHypertension, 2003
- Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesNew England Journal of Medicine, 2001
- Follow-up of renal function in treated and untreated older patients with isolated systolic hypertensionJournal Of Hypertension, 2001
- Publication and related bias in meta-analysisJournal of Clinical Epidemiology, 2000
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Blood Pressure and End-Stage Renal Disease in MenNew England Journal of Medicine, 1996
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyNew England Journal of Medicine, 1993
- Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials.BMJ, 1991